Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 5:57 PM EDT

125.35

+0.35 (+0.28%)

Volume

125,417

125.00

-0.59 (-0.47%)

Volume

4,338,492

52 week range

62.55 - 142.79

Open125.00
Day High126.40
Day Low122.01
Prev Close125.59
52 Week High142.79
52 Week High Date05/24/23
52 Week Low62.55
52 Week Low Date11/02/23

Key Stats

Market Cap47.86B
Shares Out382.88M
10 Day Average Volume3.84M
Dividend-
Dividend Yield-
Beta1.50
YTD % Change25.69

KEY STATS

Open125.00
Day High126.40
Day Low122.01
Prev Close125.59
52 Week High142.79
52 Week High Date05/24/23
52 Week Low62.55
52 Week Low Date11/02/23
Market Cap47.86B
Shares Out382.88M
10 Day Average Volume3.84M
Dividend-
Dividend Yield-
Beta1.50
YTD % Change25.69

RATIOS/PROFITABILITY

EPS (TTM)-15.66
P/E (TTM)-7.98
Fwd P/E (NTM)-16.26
EBITDA (TTM)-3.617B
ROE (TTM)-28.59%
Revenue (TTM)6.848B
Gross Margin (TTM)31.47%
Net Margin (TTM)-68.84%
Debt To Equity (MRQ)4.15%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Moderna Inc

Interest rates and the AI rally stay top of mind for stock investors next week3 Hours AgoCNBC.com
Stocks making the biggest moves midday: Apple, Peloton, Wayfair and moreMay 2, 2024CNBC.com
Stocks making the biggest premarket moves: Peloton, Carvana, Cigna and moreMay 2, 2024CNBC.com
Moderna CEO Stephane Bancel on Q1 results: The vaccine platform is coming together very nicelyMay 2, 2024CNBC.com
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take holdMay 2, 2024CNBC.com

Content From Our Affiliates

Analysts Are Bullish on These Healthcare Stocks: Elevation Oncology (ELEV), Moderna (MRNA)10 Hours AgoTipRanks
RBC Capital Remains a Buy on Moderna (MRNA)11 Hours AgoTipRanks
Moderna Reports Earnings: Did it Beat Estimate Forecasts?24 Hours AgoTipRanks
Moderna’s Hold Rating Maintained Amidst Positive Sales Outlook and Awaited RSV Vaccine LaunchMay 2, 2024TipRanks
Unusually active option classes on open May 2ndMay 2, 2024TipRanks

Profile

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the...

Noubar Afeyan Ph.D.

Non-Executive Independent Chairman of the Board, Co-Founder

Stephane Bancel

Chief Executive Officer, Director

Stephen Hoge M.D.

President

Jerh Collins

Chief Technical Operations and Quality Officer

James Mock

Chief Financial Officer

Brad Miller

Chief Information Officer

Address

325 BINNEY STREET

Cambridge, MA

02142

United States

https://www.modernatx.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ILMN Illumina Inc	117.93	-6.06	-4.89%
BNTX Biontech SE	92.72	+0.48	+0.52%
BIIB Biogen Inc	217.51	+4.00	+1.87%
CRL Charles River Laboratories International Inc	233.47	+3.58	+1.56%
GMAB Genmab A/S	29.72	+2.00	+7.22%